# Curocell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curocell

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.curocellbtx.com
- Total disclosed funding: $52M
- Latest round: Series C (Aug 7, 2020)
- Investors on record: 18

## About

Founded in 2016 and based in Daejeon, South Korea, Curocell Inc. operates as a medical technology company that researches and develops anti-cancer cell gene therapies. The company's CEO, Gunsoo Kim graduated from Yonsei University. In 2020, It completed GMP manufacturing for clinical sample production of immune cell therapy products. In 2019, it signed MOU With Samsung Seoul Hospital for joint research on immunotherapy.

The company is developing OVIS™ technology to enhance immune cells and overcome immune suppression in tumor microenvironments. The company's pipelines can be categorized into CD19 CAR-T and BCMA CAR-T. The CD19 CAR-T is used to treat lymphoma patients. The BCMA CAR-T is used to treat multiple myeloma patients

## Funding rounds

- Series C, Aug 7, 2020, $37M — AJU IB Investment, LB Investment, Atinum Investment, Seoul Investment Partners, IMM Investment, Company K Partners, K2 Investment Partners, Quad Asset Management, STIC Ventures, JX Partners, Hana Ventures, Ulmus Investment, Ryukyung PSG Asset Management, E & Venture Partners, DS Asset Management
- Series B, Jan 22, 2019, $13M — InterVest, Atinum Investment, Time Folio Asset Management, STIC Ventures, Mirae Asset Capital
- Series A, Dec 19, 2017, $1.8M — InterVest, Mirae Asset Capital

## Investors

- InterVest (https://capitalatlas.ai/funds/intervest) — Series A, Series B
- Mirae Asset Capital (https://capitalatlas.ai/funds/mirae-asset-capital) — Series A, Series B
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series B, Series C
- Time Folio Asset Management — Series B
- STIC Ventures (https://capitalatlas.ai/funds/stic-ventures) — Series B, Series C
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series C
- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series C
- Seoul Investment Partners (https://capitalatlas.ai/funds/seoul-investment-partners) — Series C
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series C
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series C
- K2 Investment Partners (https://capitalatlas.ai/funds/k2-investment-partners) — Series C
- Quad Asset Management — Series C
- JX Partners (https://capitalatlas.ai/funds/jx-partners) — Series C
- Hana Ventures — Series C
- Ulmus Investment (https://capitalatlas.ai/funds/ulmus-investment) — Series C
- Ryukyung PSG Asset Management — Series C
- E & Venture Partners (https://capitalatlas.ai/funds/e-venture-partners-2) — Series C
- DS Asset Management (https://capitalatlas.ai/funds/ds-asset-management) — Series C